OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
Joan T. Merrill, Yoshiya Tanaka, David D’Cruz, et al.
Arthritis & Rheumatology (2024)
Open Access | Times Cited: 6
Joan T. Merrill, Yoshiya Tanaka, David D’Cruz, et al.
Arthritis & Rheumatology (2024)
Open Access | Times Cited: 6
Showing 6 citing articles:
Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches
Kaoru Saegusa, Yumi Tsuchida, Toshihiko Komai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 929-929
Open Access
Kaoru Saegusa, Yumi Tsuchida, Toshihiko Komai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 929-929
Open Access
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Therapeutic Inhibition of the JAK-STAT pathway in the treatment of Inflammatory Bowel Disease.
Zihan Chen, Ping Jiang, Dan Su, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 1-15
Closed Access | Times Cited: 4
Zihan Chen, Ping Jiang, Dan Su, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 1-15
Closed Access | Times Cited: 4
Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus
Ann E. Clarke, Megan R.W. Barber, Bryce Barr, et al.
Canadian rheumatology today. (2024)
Closed Access
Ann E. Clarke, Megan R.W. Barber, Bryce Barr, et al.
Canadian rheumatology today. (2024)
Closed Access
Fine-tuning SLE treatment: the potential of selective TYK2 inhibition
Yurie Satoh, Shingo Nakayamada, Yoshiya Tanaka
RMD Open (2024) Vol. 10, Iss. 4, pp. e005072-e005072
Open Access
Yurie Satoh, Shingo Nakayamada, Yoshiya Tanaka
RMD Open (2024) Vol. 10, Iss. 4, pp. e005072-e005072
Open Access
The Immunomodulatory Mechanisms of BTK Inhibition in CLL and Beyond
Qu Jiang, Yayi Peng, Carmen D. Herling, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3574-3574
Open Access
Qu Jiang, Yayi Peng, Carmen D. Herling, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3574-3574
Open Access
